According to the study, MRF can improve glioma diagnosis, prognosis, and treatment planning by providing non-invasive information about the genetic composition of gliomas, identifying IDH mutations, distinguishing between glioblastomas and lower-grade gliomas, and monitoring tumor features. Here, IDH1 is linked to glioma.